Tranylcypromine Sulfate Tablet shortage
To Be Discontinued 1 presentations · 1 manufacturers · first FDA posting 2025-10-21 · last update 2025-10-21
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Parnate, Tablet, 10 mg (NDC 0591-5590-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Supply is expected to be depleted by 12/31/2025. | Posted 10/21/2025 Updated 10/21/2025 Discontinued 10/21/2025 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)